Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Klein

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
NPJ Digital Medicine|September 16, 2021
Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learningBernhard Kainz, Mattias P Heinrich, Antonios Makropoulos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trialMichael Ramharter, Sunny Oyakhirome, Peter Klein Klouwenberg, et al.
British Journal of Haematology|August 7, 2012
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trialWolfgang U Knauf, Toshko Lissitchkov, Ali Aldaoud, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)Sandra Gottschling, Esther Herpel, Wilfried E E Eberhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemiaWolfgang U Knauf, Toshko Lissichkov, Ali Aldaoud, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complexJune Goto, Delia M Talos, Peter Klein, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position PaperBenilde Cosmi, Agata Stanek, Matja Kozak, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 25, 2026
Seasonal Dynamics of Influenza and RSV in the Caribbean: A Call for Regionally Tailored Preventive MeasuresCharlene Maria, Jayant Kalpoe, Angelino Tromp, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 13, 2017
ESVM guidelines - the diagnosis and management of Raynaud's phenomenonJill Belch, Anita Carlizza, Patrick H Carpentier, et al.
The Journal of Infectious Diseases|November 17, 2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trialMartin P Grobusch, Bertrand Lell, Norbert G Schwarz, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
NPJ Digital Medicine|September 16, 2021
Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learningBernhard Kainz, Mattias P Heinrich, Antonios Makropoulos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trialMichael Ramharter, Sunny Oyakhirome, Peter Klein Klouwenberg, et al.
British Journal of Haematology|August 7, 2012
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trialWolfgang U Knauf, Toshko Lissitchkov, Ali Aldaoud, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)Sandra Gottschling, Esther Herpel, Wilfried E E Eberhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemiaWolfgang U Knauf, Toshko Lissichkov, Ali Aldaoud, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complexJune Goto, Delia M Talos, Peter Klein, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position PaperBenilde Cosmi, Agata Stanek, Matja Kozak, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 25, 2026
Seasonal Dynamics of Influenza and RSV in the Caribbean: A Call for Regionally Tailored Preventive MeasuresCharlene Maria, Jayant Kalpoe, Angelino Tromp, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 13, 2017
ESVM guidelines - the diagnosis and management of Raynaud's phenomenonJill Belch, Anita Carlizza, Patrick H Carpentier, et al.
The Journal of Infectious Diseases|November 17, 2007
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trialMartin P Grobusch, Bertrand Lell, Norbert G Schwarz, et al.
Pageof 14